Published in Euro Surveill on June 01, 2007
The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev (2010) 4.48
Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol (2009) 3.66
Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol (2010) 2.32
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol (2010) 2.29
The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun (2012) 2.02
Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One (2008) 1.88
Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev (2013) 1.85
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother (2008) 1.71
Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol (2011) 1.65
Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study. BMC Infect Dis (2014) 1.41
Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1. Infect Immun (2009) 1.35
Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains. J Clin Microbiol (2008) 1.30
Clostridium difficile infection: new insights into management. Mayo Clin Proc (2012) 1.23
Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J Med Microbiol (2011) 1.16
Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review. Dig Dis Sci (2010) 1.13
Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol (2010) 1.12
Typing Clostridium difficile strains based on tandem repeat sequences. BMC Microbiol (2009) 1.06
Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro. Antimicrob Agents Chemother (2009) 0.91
Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection. J Clin Microbiol (2011) 0.89
Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile. CMAJ (2009) 0.87
Rapid detection of the Clostridium difficile ribotype 027 tcdC gene frame shift mutation at position 117 by real-time PCR and melt curve analysis. Eur J Clin Microbiol Infect Dis (2009) 0.87
The flagellin FliC of Clostridium difficile is responsible for pleiotropic gene regulation during in vivo infection. PLoS One (2014) 0.86
Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan. Antimicrob Agents Chemother (2012) 0.86
Effects of inoculum, pH, and cations on the in vitro activity of fidaxomicin (OPT-80, PAR-101) against Clostridium difficile. Antimicrob Agents Chemother (2010) 0.84
Toxigenic Clostridium difficile PCR ribotypes from wastewater treatment plants in southern Switzerland. Appl Environ Microbiol (2012) 0.83
The epidemiology and economic burden of Clostridium difficile infection in Korea. Biomed Res Int (2015) 0.82
Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology. Eur J Clin Microbiol Infect Dis (2014) 0.79
Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis. PLoS One (2016) 0.76
The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Sci Rep (2016) 0.76
Advances in the Microbiome: Applications to Clostridium difficile Infection. J Clin Med (2016) 0.75
Clinical characteristics of Clostridium difficile-associated diarrhea among patients in a tertiary care center in China. Pak J Med Sci (2016) 0.75
Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA (2000) 7.21
Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect (2006) 6.90
A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (2000) 6.12
PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol (1999) 5.58
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (1997) 5.55
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med (1998) 5.08
The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). J Hosp Infect (2001) 4.95
A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol (1998) 4.79
Clonal lines of Salmonella enterica serotype Enteritidis documented by IS200-, ribo-, pulsed-field gel electrophoresis and RFLP typing. J Med Microbiol (1994) 4.43
Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol (Berl) (2005) 4.28
Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett (1999) 4.27
Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy. Br J Surg (2012) 4.01
Analysis of left ventricular wall movement during isovolumic relaxation and its relation to coronary artery disease. Br Heart J (1976) 3.79
A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health (1999) 3.72
An adjustable fetal weight standard. Ultrasound Obstet Gynecol (1995) 3.70
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) (2003) 3.70
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother (2004) 3.69
Brow-supported spectacle frames for nasal bridge reconstruction and other deformities. Arch Ophthalmol (1993) 3.53
Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol (1994) 3.46
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Protein products of the bithorax complex in Drosophila. Cell (1984) 3.40
Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure (1999) 3.37
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect (2007) 3.27
Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol (2006) 3.05
The role of 'no-touch' automated room disinfection systems in infection prevention and control. J Hosp Infect (2012) 2.97
Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br (2005) 2.94
Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science (2013) 2.87
Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (2000) 2.79
Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1994) 2.67
Estimating the date of confinement: ultrasonographic biometry versus certain menstrual dates. Am J Obstet Gynecol (1996) 2.64
Host adapted serotypes of Salmonella enterica. Epidemiol Infect (2000) 2.58
Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis (1990) 2.52
Adverse impact of surgical site infections in English hospitals. J Hosp Infect (2005) 2.51
Distribution of Ultrabithorax proteins in Drosophila. EMBO J (1985) 2.49
Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (1986) 2.43
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39
Simple treatment for torus fractures of the distal radius. J Bone Joint Surg Br (2001) 2.39
Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect (2003) 2.33
Transfer RNA as a cofactor coupling amino acid synthesis with that of protein. Proc Natl Acad Sci U S A (1968) 2.31
Echocardiographic assessment of abnormal left ventricular relaxation in man. Br Heart J (1976) 2.30
The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill (2012) 2.29
Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis (2010) 2.26
Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev (2005) 2.25
Omeprazole, campylobacter pylori, and duodenal ulcer. Lancet (1989) 2.24
Viral gastroenteritis increases the reports of Clostridium difficile infection. J Hosp Infect (2007) 2.23
Estimation of lung volumes from chest radiographs using shape information. Thorax (1979) 2.23
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol (2001) 2.20
No time for handwashing!? Handwashing versus alcoholic rub: can we afford 100% compliance? Infect Control Hosp Epidemiol (1997) 2.19
Seasonal variations in serum 25-hydroxycholecalciferol in healthy people. Lancet (1974) 2.19
The function of PS integrins during Drosophila embryogenesis. Cell (1989) 2.19
The Drosophila PS2 antigen is an invertebrate integrin that, like the fibronectin receptor, becomes localized to muscle attachments. Cell (1987) 2.18
Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Br Heart J (1977) 2.18
Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol (2008) 2.17
Contamination of healthcare workers' hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol (2013) 2.17
The stimulation of pp60v-src kinase activity by vanadate in intact cells accompanies a new phosphorylation state of the enzyme. J Biol Chem (1984) 2.15
[Increasing incidence of scabies in France, 1999-2010, and public health implications]. Ann Dermatol Venereol (2012) 2.11
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene (2010) 2.11
Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med (1998) 2.09
Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea. J Med Microbiol (1984) 2.07
Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology (2001) 2.04
Echocardiographic features of secondary left ventricular hypertrophy. Br Heart J (1979) 2.04
Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01
The value of cortical stimulation applied to the surgery of malignant gliomas in language areas. Neurol Sci (2001) 2.00
Serotyping of Clostridium difficile. J Clin Microbiol (1988) 1.98
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis (2007) 1.97
The RNA code and protein synthesis. Cold Spring Harb Symp Quant Biol (1966) 1.96
Continuous assessment of left ventricular shape in man. Br Heart J (1975) 1.95
Antimicrobial stewardship. Clin Microbiol Infect (2008) 1.95
Sensitivity to cefotaxime of pneumococci isolated in the UK. J Antimicrob Chemother (1995) 1.95
A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect (2003) 1.94